Dextenza intraocular and Insulin glargine, recombinant Subcutaneous
Determining the interaction of Dextenza intraocular and Insulin glargine, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexamethasone ophthalmic
Brand name: Dextenza, Dexycu, Ozurdex, Maxidex
Synonyms: Dextenza (intraocular), Dextenza Insert
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextenza intraocular-Insulin glulisine
- Dextenza intraocular-Insulin Glulisine (Cartridges and Pens)
- Dextenza intraocular-Insulin Glulisine (Vials)
- Dextenza intraocular-Insulin glulisine Subcutaneous
- Dextenza intraocular-Insulin human inhaled Inhalation
- Dextenza intraocular-Insulin human regular Injection
- Insulin glargine, recombinant Subcutaneous-Dextran 40
- Insulin glargine, recombinant Subcutaneous-Dextran 70 6% in 5% Dextrose high molecular weight
- Insulin glargine, recombinant Subcutaneous-Dextran 75
- Insulin glargine, recombinant Subcutaneous-Dextran high molecular weight
- Insulin glargine, recombinant Subcutaneous-Dextranomer and Hyaluronate Derivatives (Deflux)
- Insulin glargine, recombinant Subcutaneous-Dextranomer and Hyaluronate Derivatives (Solesta)